3
Announcements
Trials
Browse
Landscape
Phase
Phase 3
1
Status
Recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Genitourinary
1
Conditions
Neoplasms
14
Pain
13
Pain, Postoperative
12
Cancer Pain
10
Agnosia
7
Chronic Pain
6
Colorectal Neoplasms
4
Colonic Neoplasms
4
Breast Neoplasms
4
Neoplasm Metastasis
3
Mucositis
3
Lung Neoplasms
3
Head and Neck Neoplasms
3
Supratentorial Neoplasms
2
Pancreatic Neoplasms
2
Pain, Intractable
2
Neoplastic Cells, Circulating
2
Multiple Myeloma
2
Lymphoma
2
Leukemia, Myeloid, Acute
2
Leukemia, Biphenotypic, Acute
2
Leukemia
2
Inflammation
2
Ileus
2
Hematologic Neoplasms
2
Wounds and Injuries
1
Waldenstrom Macroglobulinemia
1
Vesico-Ureteral Reflux
1
Uterine Cervical Neoplasms
1
Urinary Bladder Neoplasms
1
Interventions
Sunitinib
26
Everolimus
20
Bevacizumab
19
aldesleukin
18
Sorafenib
16
Nivolumab
16
Interleukin-2
14
pembrolizumab
13
Peripheral Blood Stem Cell Transplantation
13
fludarabine phosphate
12
Radiotherapy
12
Interferon-alpha
12
Cyclophosphamide
12
Radiosurgery
11
Filgrastim
11
Blood Specimen Collection
11
Ipilimumab
10
Gemcitabine
10
Axitinib
9
Surveys and Questionnaires
7
Gene Expression Profiling
7
Cryosurgery
7
temsirolimus
6
pazopanib
6
Surgical Procedures, Operative
6
durvalumab
5
cabozantinib
5
atezolizumab
5
Mycophenolic Acid
5
Immunohistochemistry
5
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
OTHER
×
Kidney Neoplasms
×
Morphine
×
Clear all
NCT06349668
2026-02-05
SMILe
University Hospital, Linkoeping
Phase 3
Recruiting
220 enrolled